Results
1 -
10 of
108Lee Suk Ho, Song Kwang-Seop, Kim Jong Yup, Kang Misuk, Lee Jun Sung, Cho Seung-Hwan, Park Hyun-Ju, Kim Jeongmin, Lee Jinhwa.
Novel thiophenyl C-aryl glucoside SGLT2 inhibitors as potential antidiabetic agents, Bioorganic & Medicinal Chemistry, 2011 Xu Ge, Lv Binhua, Roberge Jacques Y., Xu Baihua, Du Jiyan, Dong Jiajia, Chen Yuanwei, Peng Kun, Zhang Lili, Tang Xinxing, Feng Yan, Xu Min, Fu Wei, Zhang Wenbin, Zhu Liangcheng, Deng Zhongping, Sheng Zelin, Welihinda Ajith, Sun Xun.
Design, Synthesis, and Biological Evaluation of DeuteratedC-Aryl Glycoside as a Potent and Long-Acting Renal Sodium-Dependent Glucose Cotransporter 2 Inhibitor for the Treatment of Type 2 Diabetes, Journal of Medicinal Chemistry, 2014 Putapatri Siddamal Reddy, Kanwal Abhinav, Banerjee Sanjay K., Kantevari Srinivas.
Synthesis of novel l-rhamnose derived acyclic C-nucleosides with substituted 1,2,3-triazole core as potent sodium-glucose co-transporter (SGLT) inhibitors, Bioorganic & Medicinal Chemistry Letters, 2014 A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus, Endocrine Discovery and Development of Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Dapagliflozin for the Treatment of Type 2 Diabetes, Carbohydrates as Drugs New and Future Therapies, Managing Diabetes SGLT2 Inhibitors for Treating Diabetes, Essentials of SGLT2 Inhibitors in Diabetes Elevated serum magnesium associated with SGLT2 inhibitor use in type 2 diabetes patients: a meta-analysis of randomised controlled trials, Diabetologia Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+/H+ exchanger, lowering of cytosolic Na+ and vasodilation, Diabetologia